Skip to main content
Livermore
Livermore
ZHEN

DeepCurrents Investment Group LLC

SEC CIK
0001754535
Latest filing
Aug 14, 2026

The latest 13F from DeepCurrents Investment Group LLC covers Q2 2026 (filed Aug 14, 2026): 103 long positions worth $2.92B. The top 10 holdings make up 33.7% of the portfolio, and the largest is InterDigital, Inc. at 5.3%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
33
Est. +$637.6M
Added
5
Est. +$3.74M
Reduced
2
Est. −$3.09M
Sold out
29
Est. −$529.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. InterDigital, Inc.45867GAD3
    5.3%$153.2M
  2. Applied Digital Corp.038169AB4
    4.8%$139.2M
  3. Repligen Corp759916AD1
    3.3%$96.8M
  4. MKS Inc55306NAB0
    3.1%$91.6M
  5. Snowflake Inc.833445AB5
    3.1%$91.6M

Share of portfolio

Top 5 holdings and the other 98 positions, by share of portfolio value

  1. InterDigital, Inc.5.3%
  2. Applied Digital Corp.4.8%
  3. Repligen Corp3.3%
  4. MKS Inc3.1%
  5. Snowflake Inc.3.1%
  6. Other 98 positions80.4%

Biggest buys

New and added positions, by estimated amount bought

  1. Applied Digital Corp.038169AB4
    +$139.2MNew
  2. Xometry, Inc.98423FAD1
    +$70.1MNew
  3. Guardant Health, Inc.40131MAB5
    +$50.1MNew
  4. On Semiconductor Corp682189AS4
    +$45.8MNew
  5. GameStop Corp.36467WAE9
    +$41.4MNew

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Applied Digital Corp.038169AB4
    +4.77 pp0.0% → 4.8%
  2. Xometry, Inc.98423FAD1
    +2.40 pp0.0% → 2.4%
  3. Guardant Health, Inc.40131MAB5
    +1.72 pp0.0% → 1.7%
  4. On Semiconductor Corp682189AS4
    +1.57 pp0.0% → 1.6%
  5. GameStop Corp.36467WAE9
    +1.42 pp0.0% → 1.4%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Ascendis Pharma A/S04351PAD3
    −$73.3MSold out
  2. Coinbase Global, Inc.19260QAB3
    −$58.4MSold out
  3. CONMED Corp207410AH4
    −$49.5MSold out
  4. Apellis Pharmaceuticals, Inc.03753UAB2
    −$47.2MSold out
  5. Callaway Golf Co131193AE4
    −$45.8MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Ascendis Pharma A/S04351PAD3
    −3.02 pp3.0% → 0.0%
  2. Coinbase Global, Inc.19260QAB3
    −2.40 pp2.4% → 0.0%
  3. CONMED Corp207410AH4
    −2.04 pp2.0% → 0.0%
  4. Apellis Pharmaceuticals, Inc.03753UAB2
    −1.94 pp1.9% → 0.0%
  5. Callaway Golf Co131193AE4
    −1.88 pp1.9% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$2.92B
+$484.3M (+19.9%) vs. prior quarter
Positions
103
+4 vs. prior quarter
Top 10 concentration
33.7%
Top 10 as share of value
Turnover
19.9%
Q2 2026, one quarter
Average holding period
4.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.30B (Q3 2021)

Q1 2021: $2.53BQ2 2021: $3.23BQ3 2021: $3.30BQ4 2021: $3.17BQ1 2022: $2.90BQ2 2022: $2.30BQ3 2022: $2.37BQ4 2022: $2.36BQ1 2023: $2.32BQ2 2023: $2.33BQ3 2023: $2.14BQ4 2023: $2.59BQ1 2024: $2.42BQ2 2024: $2.49BQ3 2024: $3.12BQ4 2024: $3.02BQ1 2025: $2.88BQ2 2025: $2.73BQ3 2025: $3.06BQ4 2025: $2.69BQ1 2026: $2.43BQ2 2026: $2.92B
Q1 2021Q2 2026
13F filings of DeepCurrents Investment Group LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026103$2.92BInterDigital, Inc.Applied Digital Corp.Repligen Corpvs. Q1 2026SEC
Q1 2026May 15, 202699$2.43BInterDigital, Inc.Repligen CorpCloudflare, Inc.vs. Q4 2025SEC
Q4 2025Feb 13, 2026109$2.69BInterDigital, Inc.Spotify USA IncCloudflare, Inc.vs. Q3 2025SEC
Q3 2025Nov 14, 2025108$3.06BBloom Energy CorpSea LtdNova Ltd.vs. Q2 2025SEC
Q2 2025Aug 14, 2025135$2.73BSea LtdNova Ltd.SHIFT4 PMTS Incvs. Q1 2025SEC
Q1 2025May 15, 2025146$2.88BSea LtdINSMED IncSHIFT4 PMTS Incvs. Q4 2024SEC
Q4 2024Feb 14, 2025137$3.02BSea LtdSHIFT4 PMTS IncCinemark Hldgs Incvs. Q3 2024SEC
Q3 2024Nov 14, 2024141$3.12BInsight Enterprises IncSea LtdNova Ltd.vs. Q2 2024SEC
Q2 2024Aug 14, 2024122$2.49BNova Ltd.Insight Enterprises IncCyberark Software Ltdvs. Q1 2024SEC
Q1 2024May 15, 2024134$2.42BInsight Enterprises IncZscaler, Inc.Cyberark Software Ltdvs. Q4 2023SEC
Q4 2023Feb 14, 2024129$2.59BPinduoduo IncZscaler, Inc.Insight Enterprises Incvs. Q3 2023SEC
Q3 2023Nov 14, 2023123$2.14BPinduoduo IncCinemark Hldgs IncBill Com Hldgs Incvs. Q2 2023SEC
Q2 2023Aug 14, 2023119$2.33BDexcom IncPinduoduo IncLivent Corp.vs. Q1 2023SEC
Q1 2023May 15, 2023116$2.32BDexcom IncIonis Pharmaceuticals IncPinduoduo Incvs. Q4 2022SEC
Q4 2022Feb 14, 2023149$2.36BDexcom IncSarepta Therapeutics, Inc.Ionis Pharmaceuticals Incvs. Q3 2022SEC
Q3 2022Nov 14, 2022187$2.37BDexcom IncSarepta Therapeutics, Inc.Zscaler, Inc.vs. Q2 2022SEC
Q2 2022Aug 15, 2022196$2.30BDexcom IncSarepta Therapeutics, Inc.Bilibili Inc.vs. Q1 2022SEC
Q1 2022May 16, 2022201$2.90BDexcom IncSarepta Therapeutics, Inc.Zscaler, Inc.vs. Q4 2021SEC
Q4 2021Feb 14, 2022199$3.17BTesla, Inc.Dexcom IncSea Ltdvs. Q3 2021SEC
Q3 2021Nov 15, 2021200$3.30BSea LtdTesla, Inc.Bilibili Inc.vs. Q2 2021SEC
Q2 2021Aug 16, 2021210$3.23BBilibili Inc.Sea LtdSea Ltdvs. Q1 2021SEC
Q1 2021May 17, 2021289$2.53BTwilio IncBilibili Inc.Tesla, Inc.–SEC

13D and 13G filings

Companies where DeepCurrents Investment Group LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

1 company, largest stake first.

Companies where DeepCurrents Investment Group LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
GOSSGossamer Bio, Inc.13G7.70%37.7M sharesNewJun 11, 20261 filingJun 11, 2026SEC

Latest filings

1 filing on file made by DeepCurrents Investment Group LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by DeepCurrents Investment Group LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
GOSSGossamer Bio, Inc.Jun 11, 20268:10 PM ET13G7.70%37.7M sharesNewJun 4, 2026SEC